MediXall Group, Inc.
MDXL
$0.0001
-$0.0038-97.44%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 154.29% | 0.14% | 66.55% | -60.17% | 7.28% |
| Total Depreciation and Amortization | -11.11% | -18.18% | -95.96% | 1,992.31% | 0.00% |
| Total Amortization of Deferred Charges | -765.26% | 0.00% | 171.43% | -94.55% | 6.29% |
| Total Other Non-Cash Items | -- | -- | -- | -66.67% | 0.00% |
| Change in Net Operating Assets | -93.82% | 8.44% | -84.33% | 863.23% | -17.33% |
| Cash from Operations | -35.18% | 4.73% | -53.33% | 23.68% | 16.43% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -47.55% | -22.42% | 73.78% | -20.59% | -23.22% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 45.42% | -22.42% | 73.78% | -20.59% | -23.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.70% | -149.19% | 3,818.18% | 112.36% | -154.60% |